Unrated Drug recall · FDA · Published December 22, 2025

Rheumacare capsules recalled for lead contamination

HANDELNINE GLOBAL LLC recalls Rheumacare capsules due to lead contamination found in manufacturing. Affected lots: CAM040 (exp 06/30/2029) and CAL079-N (exp 09/30/2028).

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0332-2026Drug HANDELNINE GLOBAL LLC ›

HANDELNINE GLOBAL LLC — official photo 1 — Official FDA recall photos · click to enlarge

Recall notice

CGMP Deviations: product found to contain lead.

Take action

Contact the company

Recalling firmHANDELNINE GLOBAL LLCSouth Plainfield, 4300 S Clinton Ave · South Plainfield, NJ 07080-1219

✎ GovInfoNow plain-language explainer

HANDELNINE GLOBAL LLC is recalling Rheumacare capsules that were manufactured in India and found to contain lead. This poses a health risk, especially for children and pregnant women who may be exposed through ingestion. Read more at govinfonow.com/recall/31603-rheumacare-capsules-recalled-for-lead-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/31603-rheumacare-capsules-recalled-for-lead-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0332-2026

Cite this page

“Rheumacare capsules recalled for lead contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31603-rheumacare-capsules-recalled-for-lead-contamination. Based on FDA recall #D-0332-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0332-2026%22&limit=1).

HANDELNINE GLOBAL LLC voluntarily recalled Rheumacare capsules due to CGMP deviations resulting in lead contamination, the FDA announced on Dec. 22, 2025. The Class I recall affects products distributed to one customer in New York.

How to tell if you have it

Rheumacare capsules, 30 count bottle
UPC 8 904218 700313
Lot CAM040, Exp. 06/30/2029
Lot CAL079-N, Exp. 09/30/2028

The hazard

The FDA stated the product was found to contain lead due to CGMP deviations. The recall is classified as Class I.

Context

GovInfoNow's records show other recent recalls of similar products include Acella Naproxen Suspension Recall (2026-04-20), Taro Recalls Children's Ibuprofen Due to Foreign Substance (2026-03-02) and Hikma Ramipril Capsules 10mg Recall: Impurity Risk (2026-08-24).

How to tell if you have this one

Check for the UPC 8 904218 700313 on the bottle. The recalled lots are CAM040 (expiring 06/30/2029) and CAL079-N (expiring 09/30/2028).

Brand
HANDELNINE GLOBAL LLC
Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the UPC 8 904218 700313 on the bottle and check the lot number against CAM040 or CAL079-N.

Where it went and when

Where it was distributed

Distributed in New York.

FDA distribution: “Product was distributed to one customer in NY.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New York.

Recall timeline

FDA published this recall 51 days after the firm started it.

Dec 22, 2025Firm started the recall
Feb 11, 2026Published in FDA’s Enforcement Report
Feb 12, 2026FDA classified it Class I

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/31603-rheumacare-capsules-recalled-for-lead-contamination">Rheumacare capsules recalled for lead contamination (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0332-2026 (December 22, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0332-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.